Title |
North Carolina A&T University-Wake Forest Cancer Center partnership (1of 2)
|
Institution |
NORTH CAROLINA AGRI & TECH ST UNIV, GREENSBORO, NC
|
Principal Investigator |
Smith, Mary
|
NCI Program Director |
Carmen Moten
|
Cancer Activity |
Comp Min Biomed Prog
|
Division |
CRCHD
|
Funded Amount |
$255,482
|
Project Dates |
09/25/2008 - 08/31/2012
|
Fiscal Year |
2010
|
Project Type |
Grant
|
Research Topics w/ Percent Relevance |
Cancer Types w/ Percent Relevance |
Cancer (100.0%)
Aging (6.3%)
Chemoprevention (25.0%)
|
Brain (25.0%)
Prostate (25.0%)
|
Research Type |
Resources and Infrastructure
Resources and Infrastructure Related to Cancer Control, Survivorship, and Outcomes Research
|
Abstract |
This P20 proposal presents a research and educational partnership between the Wake Forest University
Comprehensive Cancer Center (WFUCCC) and the Departments of Biology and Chemistry of North Carolina
Agricultural and Technical University (NC A&T). The objectives of the partnership are: (1) to foster cancer
research collaborations between WFUCCC and NC A&T, especially research focused on cancer disparities and to
facilitate the career development of minority cancer research faculty at NC A&T through collaborations with and
mentoring provided by the WFUCCC; (2) to foster interest in obtaining a PhD in cancer biology among minority
undergraduate and Master's degree students at NC A&T. To achieve the first objective, the P20 will provide pilot
funds for two collaborative research projects: (1) Drs. Suzy Torti and Yong Chen of the WFUCCC will mentor and
collaborate with Dr. Marion Franks, Assistant Professor of Chemistry at NC A&T, on a project to synthesize and
evaluate novel benzylidenes as prostate cancer chemopreventive agents; (2) Dr. Waldemar Debinski, Director of
the Brain Tumor Center of the WFUCCC, will mentor and collaborate with Dr. Patrick Martin, Assistant Professor
of Biology at NC A&T on a project to understand the role of transcription factor Fral in glioblastoma cell
mobility and resistance to therapeutics.. To achieve the second objective: (1) Selected RISE, MARC, and BLEND
program undergraduates at NC A&T will participate in wet laboratory, computational biology, or health disparity
outreach projects mentored by WFUCCC faculty; (2) Each pilot project team will select at least one NC A&T
Master's degree student to participate in the project. The students will be offered the option of continued
participation in the projects as PhD students in Cancer Biology at WFU; (3) WFUCCC and NC A&T faculty will
collaborate to develop didactic teaching modules in cancer genomics and animal models of cancer for currently
ongoing coursework at NC A&T. By the conclusion of the P20 it is expected that: (1) Drs. Franks and Martin and
their WFUCCC collaborators will be writing joint ROls; (2) The WFUCCC and NC A&T will be writing an R25
bridge application to support enrollment of NC A&T students in the PhD program in Cancer Biology at WFU. |